RESUMO
Rewiring the injured corticospinal tract (CST) by promoting connections between CST axons and spared neurons is a strategy being explored experimentally to achieve improved recovery of motor function after spinal cord injury (SCI). Reliable interventions to promote and direct growth of collaterals from injured CST axons are in high demand to promote functionally relevant detour pathways. A promising tool is neurotrophin-3 (NT-3), which has shown growth-stimulating and chemo-attractive effects for spared CST axons caudal to a CST lesion. Yet, efforts to promote growth of injured CST axons rostral to a SCI with NT-3 have been less successful to date. Evidence indicates that immune activation in the local growth environment, either intrinsic or induced by the endotoxin lipopolysaccharide (LPS), can play a decisive role in the CST's responsiveness to NT-3. Here, we test the potential of NT-3 as a tool to enhance and direct collateral growth from the injured CST rostral to a SCI (1) using long-term expression of NT-3 by adeno-associated viral vectors, (2) with and without stimulating the immune system with LPS. Our results indicate that inducing a growth response from injured CST axons into a region of vector-mediated NT-3 expression is possible in the environment of the spinal cord rostral to a SCI, but seems dependent on the distance between the responding axon and the source of NT-3. Our findings also suggest that injured CST axons do not increase their growth response to NT-3 after immune activation with LPS in this environment. In conclusion, this is to our knowledge the first demonstration that NT-3 can be effective at promoting growth of injured CST collaterals far rostral to a SCI. Making NT-3 available in close proximity to CST target axons may be the key to success when using NT-3 to rewire the injured CST in future investigations.
Assuntos
Axônios/metabolismo , Regeneração Nervosa/fisiologia , Neurotrofina 3/metabolismo , Tratos Piramidais/metabolismo , Traumatismos da Medula Espinal/fisiopatologia , Medula Espinal/metabolismo , Animais , Feminino , Plasticidade Neuronal/fisiologia , Neurônios/metabolismo , Tratos Piramidais/fisiopatologia , Ratos Endogâmicos Lew , Recuperação de Função Fisiológica/efeitos dos fármacos , Traumatismos da Medula Espinal/metabolismoRESUMO
Promoting the rewiring of lesioned motor tracts following a spinal cord injury is a promising strategy to restore motor function. For instance, axonal collaterals may connect to spared, lesion-bridging neurons, thereby establishing a detour for descending signals and thus promoting functional recovery. In our rat model of cervical spinal cord injury, we attempted to promote targeted rewiring of the unilaterally injured corticospinal tract (CST) via the spared reticulospinal tract (RtST). To promote new connections between the two tracts in the brainstem, we administered viral vectors producing two neurotrophins. Brain-derived neurotrophic factor (BDNF), a known promotor of collateral growth, was expressed in the motor cortex, and neurotrophin 3 (NT-3), which has chemoattractive properties, was expressed in the reticular formation. Because rehabilitative training has proven to be beneficial in promoting functionally meaningful plasticity following injury, we added training in a skilled reaching task. Different neurotrophin or control treatments with or without training were evaluated. As hypothesized, improvements of motor performance with the injured forelimb following neurotrophin treatment alone were absent or modest compared to untreated controls. In contrast, we found a significant synergistic effect on performance when BDNF treatment was combined with training. The mechanism of this recovery remains unidentified, as histological analyses of CST and RtST collateral projections did not reveal differences among treatment groups. In conclusion, we demonstrate that following a cervical spinal lesion, rehabilitative training is necessary to translate effects of BDNF into functional recovery by mechanisms which are likely independent of collateral sprouting of the CST or RtST into the gray matter.
Assuntos
Fator Neurotrófico Derivado do Encéfalo/uso terapêutico , Neurotrofina 3/uso terapêutico , Tratos Piramidais/fisiologia , Traumatismos da Medula Espinal/reabilitação , Traumatismos da Medula Espinal/terapia , Adenoviridae , Animais , Fator Neurotrófico Derivado do Encéfalo/administração & dosagem , Células Cultivadas , Vértebras Cervicais , Modelos Animais de Doenças , Feminino , Expressão Gênica/genética , Vetores Genéticos/administração & dosagem , Destreza Motora/fisiologia , Regeneração Nervosa/genética , Regeneração Nervosa/fisiologia , Neurotrofina 3/administração & dosagem , Ratos , Ratos Endogâmicos Lew , Recuperação de Função Fisiológica/genéticaRESUMO
Huntington's disease (HD) is a neurodegenerative disorder characterized by progressive neuronal death in the basal ganglia and cortex. Although increasing evidence supports a pivotal role of mitochondrial dysfunction in the death of patients' neurons, the molecular bases for mitochondrial impairment have not been elucidated. We provide the first evidence of an abnormal activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein 3 (BNip3) in cells expressing mutant Huntingtin. In this study, we show an abnormal accumulation and dimerization of BNip3 in the mitochondria extracted from human HD muscle cells, HD model cell cultures and brain tissues from HD model mice. Importantly, we have shown that blocking BNip3 expression and dimerization restores normal mitochondrial potential in human HD muscle cells. Our data shed light on the molecular mechanisms underlying mitochondrial dysfunction in HD and point to BNip3 as a new potential target for neuroprotective therapy in HD.
Assuntos
Proteínas de Membrana/metabolismo , Proteínas Mitocondriais/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas Nucleares/genética , Proteínas Proto-Oncogênicas/metabolismo , Animais , Linhagem Celular , Dimerização , Modelos Animais de Doenças , Humanos , Proteína Huntingtina , Doença de Huntington/metabolismo , Potencial da Membrana Mitocondrial , Proteínas de Membrana/análise , Camundongos , Mitocôndrias/metabolismo , Proteínas Mitocondriais/análise , Células Musculares/metabolismo , Mutação , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/metabolismo , Proteínas Proto-Oncogênicas/análiseRESUMO
AIM/HYPOTHESIS: Embryonic stem (ES) cells have been proposed as a potential source of tissue for transplantation for the treatment of Type 1 diabetes. However, studies showing differentiation of beta cells from ES cells are controversial. The aim of this study was to characterise the insulin-expressing cells differentiated in vitro from ES cells and to assess their suitability for the treatment of diabetes. METHODS: ES cell-derived insulin-expressing cells were characterised by means of immunocytochemistry, RT-PCR and functional analyses. Activation of the Insulin I promoter during ES-cell differentiation was assessed in ES-cell lines transfected with a reporter gene. ES cell-derived cultures were transplanted into STZ-treated SCID-beige mice and blood glucose concentrations of diabetic mice were monitored for 3 weeks. RESULTS: Insulin-stained cells differentiated from ES cells were devoid of typical beta-cell granules, rarely showed immunoreactivity for C-peptide and were mostly apoptotic. The main producers of proinsulin/insulin in these cultures were neurons and neuronal precursors and a reporter gene under the control of the insulin I promoter was activated in cells with a neuronal phenotype. Insulin was released into the incubation medium but the secretion was not glucose-dependent. When the cultures were transplanted in diabetic mice they formed teratomas and did not reverse the hyperglycaemic state. CONCLUSIONS/INTERPRETATION: Our studies show that insulin-positive cells in vitro-differentiated from ES cells are not beta cells and suggest that alternative protocols, based on enrichment of ES cell-derived cultures with cells of the endodermal lineage, should be developed to generate true beta cells for the treatment of diabetes.
Assuntos
Insulina/genética , Células-Tronco/fisiologia , Animais , Diferenciação Celular , Linhagem Celular , Genes Reporter , Ilhotas Pancreáticas/citologia , Ilhotas Pancreáticas/embriologia , Ilhotas Pancreáticas/fisiologia , Camundongos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células-Tronco/citologia , TransfecçãoRESUMO
A milestone in Huntington's disease (HD) research is represented by the identification of the causative gene. With the genetics at hand, a series of transgenic cellular and animal models has been developed, which has greatly contributed to understanding of HD. All these models are described in this review, and are compared to each other, along with the information they have generated. Although the mechanism by which progressive loss of striatal neurons occurs in HD remains uncertain, hypotheses on mutant huntingtin toxicity involve impaired vescicular trafficking, transcriptional dysregulation, and/or activation of apoptotic pathways. The development of inducible HD mice has shown that neurodegeneration in HD may be at least partially blocked. Although traditionally considered a "gain-of-function" disease, the recent finding that normal huntingtin has an important role in neuronal survival suggests that loss of function of the normal protein might contribute to HD as well, also discloseing new perspectives on the therapeutical approach to the pathology.
Assuntos
Modelos Animais de Doenças , Doença de Huntington , Animais , Animais Geneticamente Modificados , Apoptose/fisiologia , Caenorhabditis elegans , Linhagem Celular Transformada/metabolismo , Células Cultivadas/metabolismo , Células Cultivadas/patologia , Corpo Estriado/metabolismo , Corpo Estriado/patologia , Cisteína Endopeptidases/fisiologia , Drosophila melanogaster , Desenvolvimento Embrionário e Fetal/genética , Proteínas Fetais/fisiologia , Genes Dominantes , Genes Letais , Haplorrinos , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/metabolismo , Doença de Huntington/patologia , Rim , Camundongos , Camundongos Knockout , Camundongos Transgênicos , N-Metilaspartato/farmacologia , Proteínas do Tecido Nervoso/química , Proteínas do Tecido Nervoso/deficiência , Proteínas do Tecido Nervoso/genética , Proteínas do Tecido Nervoso/fisiologia , Neurônios/metabolismo , Neurônios/patologia , Proteínas Nucleares/química , Proteínas Nucleares/deficiência , Proteínas Nucleares/genética , Proteínas Nucleares/fisiologia , Células PC12/metabolismo , Fragmentos de Peptídeos/genética , Mapeamento de Interação de Proteínas , Ratos , Repetições de TrinucleotídeosRESUMO
A novel murine cDNA for triacylglycerol hydrolase (TGH), an enzyme that is involved in mobilization of triacylglycerol from storage pools in hepatocytes, has been cloned and expressed. The cDNA consists of 1962 bp with an open reading frame of 1695 bp that encodes a protein of 565 amino acids. Murine TGH is a member of the CES1A class of carboxylesterases and shows a significant degree of identity to other carboxylesterases from rat, monkey and human. Expression of the cDNA in McArdle RH7777 hepatoma cells showed a 3-fold increase in the hydrolysis of p-nitrophenyl laurate compared to vector-transfected cells. The highest expression of TGH was observed in the livers of mice, with lower expression in kidney, heart, adipose and intestinal (duodenum/jejunum) tissues. The murine gene that encodes TGH was cloned and exon-intron boundaries were determined. The gene spans approx. 35 kb and contains 14 exons. The results will permit future studies on the function of this gene via gene-targeting experiments and analysis of transcriptional regulation of the TGH gene.
Assuntos
Lipase/genética , Sequência de Aminoácidos , Animais , Sequência de Bases , Linhagem Celular , Clonagem Molecular , DNA Complementar/química , DNA Complementar/isolamento & purificação , Éxons , Regulação da Expressão Gênica , Íntrons , Lipase/química , Fígado/enzimologia , Camundongos , Dados de Sequência Molecular , Fases de Leitura Aberta , Ratos , Mapeamento por Restrição , Alinhamento de Sequência , TransfecçãoRESUMO
Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.
Assuntos
Fator Neurotrófico Derivado do Encéfalo/genética , Córtex Cerebral/metabolismo , Corpo Estriado/metabolismo , Doença de Huntington/genética , Proteínas do Tecido Nervoso/fisiologia , Neurônios/metabolismo , Proteínas Nucleares/fisiologia , Células 3T3 , Animais , Apoptose , Fator Neurotrófico Derivado do Encéfalo/biossíntese , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Sobrevivência Celular , Células Cultivadas , Córtex Cerebral/citologia , Corpo Estriado/citologia , Corpo Estriado/patologia , Éxons , Hipocampo/citologia , Hipocampo/metabolismo , Hipocampo/patologia , Humanos , Proteína Huntingtina , Doença de Huntington/metabolismo , Doença de Huntington/patologia , Camundongos , Camundongos Transgênicos , Mutação , Degeneração Neural , Fatores de Crescimento Neural/genética , Fatores de Crescimento Neural/metabolismo , Proteínas do Tecido Nervoso/genética , Neurônios/patologia , Proteínas Nucleares/genética , Regiões Promotoras Genéticas , Transcrição Gênica , TransfecçãoRESUMO
Previously we found that the availability of ShcA adapter is maximal in neural stem cells but that it is absent in mature neurons. Here we report that ShcC, unlike ShcA, is not present in neural stem/progenitor cells, but is expressed after cessation of their division and becomes selectively enriched in mature neurons. Analyses of its activity in differentiating neural stem/progenitor cells revealed that ShcC positively affects their viability and neuronal maturation via recruitment of the PI3K-Akt-Bad pathway and persistent activation of the MAPK pathway. We suggest that the switch from ShcA to ShcC modifies the responsiveness of neural stem/progenitor cells to extracellular stimuli, generating proliferation (with ShcA) or survival/differentiation (with ShcC).
Assuntos
Proteínas Adaptadoras de Transdução de Sinal , Diferenciação Celular/fisiologia , Proteínas do Tecido Nervoso/fisiologia , Neurônios/fisiologia , Células-Tronco/fisiologia , Proteínas de Transporte/metabolismo , Morte Celular , Sobrevivência Celular , Células Cultivadas , Clonagem Molecular , Fator de Crescimento Epidérmico/farmacologia , Feto , Proteínas de Fluorescência Verde , Proteínas Luminescentes/análise , Proteínas Luminescentes/genética , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Fator de Crescimento Neural/farmacologia , Proteínas do Tecido Nervoso/genética , Neurônios/citologia , Neurônios/efeitos dos fármacos , Fosfatidilinositol 3-Quinases/metabolismo , Fosforilação , Proteínas/fisiologia , Proteínas Recombinantes de Fusão/metabolismo , Proteínas Adaptadoras da Sinalização Shc , Células-Tronco/citologia , Telencéfalo/citologia , Telencéfalo/embriologia , Transfecção , Proteína de Morte Celular Associada a bcl , Domínios de Homologia de srcAssuntos
Corpo Estriado/citologia , Corpo Estriado/metabolismo , Proteínas do Tecido Nervoso/genética , Proteínas Nucleares/genética , Receptores Purinérgicos P1/metabolismo , Sistemas do Segundo Mensageiro/fisiologia , Adenosina-5'-(N-etilcarboxamida)/farmacologia , Adenilil Ciclases/metabolismo , Linhagem Celular , Colforsina/farmacologia , AMP Cíclico/metabolismo , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/metabolismo , Cinética , Modelos Biológicos , Mutação , Proteínas do Tecido Nervoso/química , Proteínas do Tecido Nervoso/metabolismo , Proteínas Nucleares/química , Proteínas Nucleares/metabolismo , Antagonistas de Receptores Purinérgicos P1 , Ensaio Radioligante , Receptor A2A de Adenosina , Receptores Purinérgicos P1/genética , Transdução de SinaisRESUMO
Huntington's Disease is an inherited neurodegenerative disease that affects the medium spiny neurons in the striatum. The disease is caused by the expansion of a polyglutamine sequence in the N terminus of Huntingtin (Htt), a widely expressed protein. Recently, we have found that Htt is an antiapoptotic protein in striatal cells and acts by preventing caspase-3 activity. Here we report that Htt overexpression in other CNS-derived cells can protect them from more than 20 days exposure to fatal stimuli. In particular, we found that cytochrome c continues to be released from mitochondria into the cytosol of cells that overexpress normal Htt. However, procaspase-9 is not processed, indicating that wild-type Htt (wtHtt) acts downstream of cytochrome c release. These data show that Htt inhibits neuronal cell death by interfering with the activity of the apoptosome complex.
Assuntos
Inibidores de Caspase , Precursores Enzimáticos/antagonistas & inibidores , Proteínas do Tecido Nervoso/fisiologia , Proteínas Nucleares/fisiologia , Apoptose/fisiologia , Caspase 9 , Caspases/metabolismo , Linhagem Celular Transformada , Grupo dos Citocromos c/metabolismo , Ativação Enzimática , Precursores Enzimáticos/metabolismo , Humanos , Proteína Huntingtina , Mitocôndrias/enzimologiaRESUMO
Huntington's disease is characterized by a loss of brain striatal neurons that occurs as a consequence of an expansion of a CAG repeat in the huntingtin protein. The resulting extended polyglutamine stretch confers a deleterious gain-of-function to the protein. Analysis of the mutant protein has attracted most of the research activity in the field, however re-examination of earlier data and new results on the beneficial functions of normal huntingtin indicate that loss of the normal protein function might actually equally contribute to the pathology. Thus, complete elucidation of the physiological role(s) of huntingtin and its mode of action are essential and could lead to new therapeutic approaches.
Assuntos
Doença de Huntington/fisiopatologia , Mutação , Proteínas do Tecido Nervoso/fisiologia , Proteínas Nucleares/fisiologia , Animais , Corpo Estriado/patologia , Humanos , Proteína Huntingtina , Doença de Huntington/genética , Doença de Huntington/patologia , Camundongos , Camundongos Knockout , Proteínas do Tecido Nervoso/deficiência , Proteínas do Tecido Nervoso/genética , Neurônios/patologia , Proteínas Nucleares/deficiência , Proteínas Nucleares/genéticaRESUMO
The ST14A cell line was previously derived from embryonic day 14 rat striatal primordia by retroviral transduction of the temperature-sensitive SV40 large T antigen. We showed that cell division and expression of nestin persists at 33 degrees C, the permissive temperature, whereas cell division ceases, nestin expression decreases, and MAP2 expression increases at the nonpermissive temperature of 39 degrees C. In this study, we further characterized the cells and found that they express other general and subtype-specific neuronal characteristics. ST14A cells express enolase and beta III-tubulin. Furthermore, they express the striatal marker DARPP-32, which is up-regulated upon differentiation of the cells by growth in serum-free medium. Stimulation with dopamine, the D2-dopamine receptor agonist quinpirole, or the D1-dopamine receptor agonist SKF82958 results in phosphorylation of CREB. Treatment of the cells with a mixture of reagents which stimulate the MAPK and adenylyl cyclase pathways radically changes the morphology of the ST14A cells. The cells develop numerous neurite-like appearing processes which stain with beta III-tubulin. Moreover, under these conditions, intracellular injection of rectangular depolarizing current stimuli elicits overshooting action potentials with a relatively fast depolarization rate when starting from a strongly hyperpolarized membrane potential. Taken together, these data imply that the ST14A cell line displays some of the characteristics of a medium-size spiny neuron subtype and provides a new tool to elucidate the pathways and molecules involved in medium-size spiny neuron differentiation and disease.
Assuntos
Proteínas do Tecido Nervoso , Neurônios/classificação , Neurônios/citologia , Potenciais de Ação/fisiologia , Adenilil Ciclases/metabolismo , Animais , Antígenos de Diferenciação/biossíntese , Divisão Celular/fisiologia , Linhagem Celular , Corpo Estriado/citologia , Corpo Estriado/embriologia , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Agonistas de Dopamina/farmacologia , Fosfoproteína 32 Regulada por cAMP e Dopamina , Estimulação Elétrica , Proteínas de Filamentos Intermediários/biossíntese , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Proteínas Associadas aos Microtúbulos/biossíntese , Nestina , Neuritos/efeitos dos fármacos , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Fosfoproteínas/biossíntese , Fosfopiruvato Hidratase/biossíntese , Fosforilação/efeitos dos fármacos , Ratos , Temperatura , Tubulina (Proteína)/biossínteseRESUMO
Expansion of a polyglutamine sequence in the N terminus of huntingtin is the gain-of-function event that causes Huntington's disease. This mutation affects primarily the medium-size spiny neurons of the striatum. Huntingtin is expressed in many neuronal and non-neuronal cell types, implying a more general function for the wild-type protein. Here we report that wild-type huntingtin acts by protecting CNS cells from a variety of apoptotic stimuli, including serum withdrawal, death receptors, and pro-apoptotic Bcl-2 homologs. This protection may take place at the level of caspase-9 activation. The full-length protein also modulates the toxicity of the poly-Q expansion. Cells expressing full-length mutant protein are susceptible to fewer death stimuli than cells expressing truncated mutant huntingtin.
Assuntos
Apoptose/fisiologia , Caspases/metabolismo , Proteínas do Tecido Nervoso/genética , Neurônios/citologia , Neurônios/enzimologia , Proteínas Nucleares/genética , Animais , Caspase 3 , Caspase 9 , Linhagem Celular Transformada , Sobrevivência Celular/fisiologia , Córtex Cerebral/citologia , Corpo Estriado/citologia , Regulação Enzimológica da Expressão Gênica , Marcação In Situ das Extremidades Cortadas , Mutagênese/fisiologia , Neurônios/química , Regiões Promotoras Genéticas/fisiologia , Proteínas Proto-Oncogênicas c-bcl-2/genética , Transfecção , Proteína bcl-XRESUMO
In microvessels isolated from bovine brain, microsomal enzyme activities involved in phosphatidylcholine biosynthesis and degradation were determined. The microvessels possessed acyl-CoA:1-acyl-sn-glycero-3-phosphocholine (AT) and glycerophosphocholine phosphodiesterase (GroPChoPDE) activity at a higher level compared with bovine and rat brain or rat liver microsomes whereas they expressed CTP:phosphocholine cytidylyltransferase (CT) and choline phosphotransferase (CPT) activity at a lower level. Each enzyme has been characterized in terms of response to inhibitors or activators revealing properties very similar to those in brain and liver microsomes. In the homogenate prepared from t-butylhydroperoxide-treated microvessels (10 min exposure to 10 microM up to 1 mM concentrations), AT and CPT activities exhibited a significant dose-dependent inhibition. In contrast, GroPChoPDE activity was unaffected. CT was inhibited only at 1 mM concentration. Short treatment of microvessels with Fe2+ (20 microM)-ascorbate (0.25 mM) or 100 microM linoleate hydroperoxide did not have any effect on the activity of the four enzymes. Strong inhibition of all enzymes was noted when the linoleate hydroperoxide system was fortified by Fe2+ ions (100 microM). AT inactivation was also found when oxidized low density lipoprotein was preincubated with microvessels. On the other hand, oxidized LDL left unchanged CPT and GroPChoPDE activities whereas it promoted a slight stimulation of cytidylyltransferase activity. Overall, the results suggest a link between oxygen radical generation and the perturbation of the microvessel membrane structure in which the four enzymes are incorporated, coupled to a direct sulfhydryl protein modification.
Assuntos
Encéfalo/irrigação sanguínea , Peroxidação de Lipídeos , Microcirculação/enzimologia , Microssomos/enzimologia , Fosfatidilcolinas/biossíntese , Animais , Bovinos , Diacilglicerol Colinofosfotransferase/metabolismo , Ativação Enzimática , Inibidores Enzimáticos/farmacologia , Cinética , Malondialdeído/metabolismo , Microssomos Hepáticos/enzimologia , Nucleotidiltransferases/metabolismo , Especificidade de Órgãos , Peróxidos/farmacologia , Diester Fosfórico Hidrolases/metabolismo , Ratos , Espécies Reativas de Oxigênio/farmacologia , Especificidade da Espécie , terc-Butil HidroperóxidoRESUMO
While steady-state kinetic parameters (metabolite pools, Km and activation energies) are partially known for the enzymes involved in phosphatidylcholine synthesis and degradation in mammalian brain, they are not available for the nervous system of lower vertebrates or invertebrates. Since the extent of evolutionary development of an enzyme is not known a priori, we evaluated the kinetic and thermodynamic parameters of choline kinase, CTP:phosphocholine cytidylyltransferase, choline phosphotransferase and glycerophosphorylcholine phosphodiesterase in squid (Loligo pealei) optic lobe, dogfish (Mustelus canis) and rat brain. For all these enzyme activities, basic similarities in Km and inhibitor effect were found. The same was true for the activation energies Ea, with the exception of squid choline kinase and dogfish cytidylyltransferase. Treatment of microsomal membranes with phospholipase C sharply inhibited cytidylyltransferase activity in all three animal species. In dogfish brain, glycerophosphorylcholine phosphodiesterase activity was undetectable. Our results are consistent with the notion that the kinetic properties of the enzyme activities leading to the preservation of the phosphatidylcholine membranous pool may have appeared early in metazoan evolution and been fully conserved in mammals.
Assuntos
Evolução Biológica , Encéfalo/enzimologia , Decapodiformes/metabolismo , Cação (Peixe)/metabolismo , Lobo Óptico de Animais não Mamíferos/enzimologia , Fosfatidilcolinas/metabolismo , Animais , Colina Quinase/antagonistas & inibidores , Colina Quinase/química , Colina Quinase/metabolismo , Colina-Fosfato Citidililtransferase , Diacilglicerol Colinofosfotransferase/antagonistas & inibidores , Diacilglicerol Colinofosfotransferase/química , Ativação Enzimática , Inibidores Enzimáticos/farmacologia , Cinética , Nucleotidiltransferases/antagonistas & inibidores , Nucleotidiltransferases/química , Nucleotidiltransferases/metabolismo , Diester Fosfórico Hidrolases/química , Diester Fosfórico Hidrolases/metabolismo , Ratos , Termodinâmica , Fosfolipases Tipo C/farmacologiaRESUMO
The blood-retina and blood-brain transport of fatty acids was studied in control and lipid hydroperoxide-treated rats by measuring the permeability-surface area product (PS) to [1-14C]palmitate. An in situ carotid perfusion method was used. PS values were evaluated: (1) just after intracarotid injection of hydroperoxides; or (2) after a short-term systemic treatment for 1 week with sonicated emulsion of phospholipids-linoleate peroxidized mixture. Compared with saline-treated rats, PS remarkably decreased in the retina and most brain regions studied after acute, arterial injection of hydroperoxide preparations. On the contrary, the transport index significantly increased in the retina and almost all the brain areas after 7 days i.v. treatment with hydroperoxide emulsion. It is suggested that hydroperoxides acutely administered before transport radiotracer brought about a reinforcement of microvasculature junctional area or hampered substrate diffusion across endothelial membrane. On the other hand, upon short-term i.v. administration, hydroperoxides presumably triggered a lipid structure derangement of endothelial cell membranes and zonulae occludens due to their local accumulation and/or high capability of generating oxygen-free radicals.
Assuntos
Barreira Hematoencefálica/efeitos dos fármacos , Barreira Hematorretiniana/efeitos dos fármacos , Peróxidos Lipídicos/farmacologia , Palmitatos/metabolismo , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Membrana Celular/efeitos dos fármacos , Membrana Celular/metabolismo , Ácidos Graxos Insaturados/metabolismo , Ratos , Ratos Sprague-Dawley , Retina/efeitos dos fármacos , Retina/metabolismoRESUMO
Two enzyme activities involved in phospholipid metabolism in the rat retina were determined after in vivo and in vitro peroxidation according to several model systems. The in vivo models were based on: (i) intravenous administration of a sonicated emulsion of phospholipid and linoleate photooxidized mixture to normal rat for a period of one week; (ii) acute injection of Fe2+ solution (20 mM) or (iii) 0.5 mg of hydroperoxylinoleate into the vitreous body, and collection of retinal tissue 4 h or 4 days later, respectively. Oleoyl CoA:lysophosphatidylcholine acyltransferase activity was unchanged or exhibited significant inhibition. On the contrary, CTP:phosphocholine cytidylyltransferase activity was stimulated. By incubating in vitro the retina with: (i) Fe(2+)-ascorbate; (ii) photooxidized phospholipid mixture (0.1-5 mM) or individual phospholipid classes; (iii) hydroperoxylinoleate (0.25-2 mM), with or without Fe2+, a significant inactivation of acyltransferase (six-fold maximum loss of initial activity) and a slight stimulation of cytidylyltransferase were seen. Altogether, the results suggest that in situ oxygen radical generation by a variety of agents irreversibly perturbs enzymes and/or membrane structures in which the enzymes are inserted; these events may bea causal factor in retinal degeneration accompanying some ocular diseases.